ArentFox Schiff advised CNS Pharmaceuticals, while Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering.CNS Pharmaceuticals, Inc. closed the $3 million registered direct offering of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
